UL Solutions Inc.

ULS ·Healthcare, Diagnostics & Research, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022
Revenue $3.05B $2.87B $2.68B $2.52B
Cost of Revenue $1.54B $1.48B $1.39B $1.31B
Gross Profit $1.51B $1.39B $1.28B $1.21B
Gross Margin 49.5% 48.5% 47.9% 47.9%
Operating Expenses
Research & Development
SG&A Expense $953.0M $931.0M $875.0M $795.0M
Operating Income $522.0M $462.0M $368.0M $412.0M
Operating Margin 17.1% 16.1% 13.7% 16.3%
Interest Expense
Pretax Income $470.0M $415.0M $346.0M $383.0M
Income Tax Expense $125.0M $70.0M $70.0M $74.0M
Net Income $325.0M $326.0M $260.0M $293.0M
Net Margin 10.6% 11.4% 9.7% 11.6%
EPS (Basic) $1.62 $1.63 $1.30 $1.47
EPS (Diluted) $1.60 $1.62 $1.30 $1.47
Shares Outstanding (Basic) 201.0M 200.0M 200.0M 200.0M
Shares Outstanding (Diluted) 203.0M 201.0M 200.0M 200.0M
Dividends Per Share $0.52 $0.50 $3.40 $8.00